Role of Peroxiredoxin 6 in Breast Cancer Progression
Author Information
Author(s): Chang Xin-Zhong, Li Da-Qiang, Hou Yi-Feng, Wu Jiong, Lu Jin-Song, Di Gen-Hong, Jin Wei, Ou Zhou-Luo, Shen Zhen-Zhou, Shao Zhi-Ming
Primary Institution: Breast Cancer Institute, Cancer Hospital, Department of Oncology, Shanghai Medical College, Institutes of Biomedical Science, Fudan University
Hypothesis
Does peroxiredoxin 6 influence the proliferation and metastatic potential of breast cancer cells?
Conclusion
Overexpression of peroxiredoxin 6 leads to a more invasive phenotype and metastatic potential in human breast cancer.
Supporting Evidence
- Peroxiredoxin 6 was found to be overexpressed in highly metastatic breast cancer cells.
- Knockdown of peroxiredoxin 6 resulted in decreased invasion and proliferation of breast cancer cells.
- PRDX6 expression was associated with increased levels of invasion-related proteins.
Takeaway
This study found that a protein called peroxiredoxin 6 helps breast cancer cells grow and spread more easily.
Methodology
The study used RT-PCR, real-time PCR, western blot, and in vivo xenograft models to assess the effects of peroxiredoxin 6 on breast cancer cells.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website